Douglas Fambrough, Chief Executive Officer at Dicerna Pharmaceuticals Inc (DRNA), bought 14,300 shares at $15.00 ($107K) on 2014-01-29, disclosed to the SEC on 2014-02-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.42 | 9,300 | $32K | 29.8% |
| 2 | $15.00 | 5,000 | $75K | 70.2% |
| Total | $7.47 avg | 14,300 | $107K | 100% |
| Filing → |
| DRNA | SELL | 2019-12-19 | $7.2M | — | Filing → |
| DRNA | BUY | 2016-11-16 | $123K | — | Filing → |